Paul Poirier | Precision Medicine | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Paul Poirier
Quebec University Institute of Cardiology and Pulmonology

Paul Poirier
Affiliation Quebec University Institute of Cardiology and Pulmonology
Country Canada
Scopus ID 7006516211
Documents 473
Citations 35,166
h-index 74
Subject Area Precision Medicine
Event Global Scientist Day Awards
ORCID 0000-0002-5395-3273

Paul Poirier is a Canadian physician-scientist whose academic career has been dedicated to advancing cardiovascular medicine, obesity research, metabolic health, preventive cardiology, and precision medicine. Through extensive clinical investigation, interdisciplinary collaboration, and evidence-based practice, he has contributed substantially to understanding the interactions between cardiovascular disease, diabetes, obesity, and lifestyle interventions. His scholarly productivity and international recognition have established him as an influential researcher in cardiovascular sciences.[1]

Abstract

Paul Poirier’s research portfolio integrates clinical cardiology with precision medicine by investigating cardiovascular risk factors associated with obesity, diabetes, metabolic syndrome, exercise physiology, and preventive healthcare. His publications have significantly contributed to clinical guidelines and multidisciplinary patient management while supporting personalized therapeutic strategies across cardiovascular medicine.[1]

Keywords

Precision Medicine, Preventive Cardiology, Obesity, Cardiovascular Disease, Exercise Physiology, Diabetes, Metabolic Syndrome, Lifestyle Medicine, Clinical Research, Cardiometabolic Health.

Introduction

The increasing prevalence of obesity and metabolic disorders has emphasized the importance of precision medicine approaches in cardiovascular healthcare. Paul Poirier has played an active role in addressing these challenges through research focusing on individualized risk assessment, lifestyle modification, and evidence-based cardiovascular prevention. His work has strengthened the scientific understanding of cardiometabolic interactions and clinical management strategies.[2]

Research Profile

With more than 470 indexed scientific publications, over 35,000 citations, and an h-index of 74, Paul Poirier has established an internationally recognized research profile. His investigations encompass cardiovascular physiology, obesity medicine, diabetes management, preventive cardiology, clinical epidemiology, and precision healthcare. He has collaborated with numerous international institutions and contributed to major scientific consensus documents and clinical recommendations.[1]

Research Impact

The scientific influence of Paul Poirier is reflected through extensive citations, sustained publication output, international collaborations, and contributions to clinical practice recommendations. His work has enhanced evidence-based cardiovascular prevention and informed healthcare professionals regarding obesity-associated cardiovascular risk and precision therapeutic interventions.[3]

Award Suitability

Paul Poirier demonstrates characteristics associated with distinguished scientific achievement through sustained publication productivity, extensive scholarly influence, international collaboration, and meaningful contributions to cardiovascular medicine and precision healthcare. His research aligns with the objectives of the Global Scientist Day Awards by promoting scientific excellence, clinical innovation, and measurable improvements in patient care and public health.[1]

Conclusion

Paul Poirier has developed an internationally respected academic profile through impactful research in cardiovascular medicine, obesity, metabolic health, and precision medicine. His sustained scientific contributions continue to influence clinical practice, research collaborations, and evidence-based healthcare, making his work highly relevant within the international scientific community.

References

  1. Elsevier (2026). Scopus author details: Paul Poirier, Author ID 7006516211. Scopus.
    https://www.scopus.com/pages/authors/7006516211
  2. Pre-exercise meal macronutrient composition and acute inflammatory response in males with type 2 diabetes mellitus.
    https://doi.org/10.1161/CIRCULATIONAHA.106.171016
  3. ORCID (2026). Paul Poirier ORCID Profile.
    https://orcid.org/0000-0002-5395-3273

Sallysamir Zahran | Drug Development | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Sallysamir Zahran
Affiliation Egyptian Atomic Energy Authority
Country Egypt
Scopus ID 56490517500
Documents 5
Citations 116
h-index 3
Subject Area Drug Development
Event Global Scientist Day Awards

Sallysamir Zahran

Institution: Egyptian Atomic Energy Authority
Country: Egypt

Sallysamir Zahran is associated with the Egyptian Atomic Energy Authority and contributes to scientific research in the interdisciplinary field of drug development. Research activities have focused on developing innovative pharmaceutical and biomedical solutions supported by experimental investigations and collaborative scientific approaches. Scholarly publications indexed in Scopus demonstrate sustained academic engagement and measurable citation impact within the international research community.[1]

Abstract

Drug development requires integration of pharmaceutical science, biomedical research, analytical methodologies, and translational innovation. Sallysamir Zahran’s scholarly work contributes to these objectives through research that supports improved therapeutic strategies and scientific understanding. The publication record indexed by Scopus reflects consistent scientific productivity, while citation metrics indicate that the research has been referenced by fellow investigators within related disciplines.[1]

Keywords

Drug Development, Pharmaceutical Sciences, Biomedical Research, Therapeutic Innovation, Drug Discovery, Translational Medicine, Experimental Pharmacology, Clinical Research, Medical Science, Scientific Publications

Introduction

Modern drug development combines chemistry, biology, pharmacology, toxicology, and clinical science to produce safe and effective therapeutic interventions. Researchers working within this multidisciplinary environment contribute to improving healthcare outcomes through systematic experimentation, validation, and scientific communication. Publications indexed by international databases such as Scopus provide evidence of research visibility and scholarly dissemination.[1]

Research Profile

Sallysamir Zahran is affiliated with the Egyptian Atomic Energy Authority and has established an academic profile within the field of drug development. According to the available Scopus author profile, the researcher has produced five indexed scholarly documents, accumulated 116 citations, and attained an h-index of 3. These indicators demonstrate measurable scientific engagement and continued participation in internationally indexed research activities.[1]

Research Contributions

The research contributions emphasize experimental investigations supporting pharmaceutical innovation and biomedical applications. Published studies contribute to scientific knowledge related to therapeutic development, laboratory evaluation, and evidence-based research methodologies. Collaborative investigations further strengthen interdisciplinary knowledge exchange while encouraging reproducibility and scientific transparency.[2]

Publications

Research publications indexed within Scopus demonstrate scholarly dissemination in drug development and associated biomedical sciences. These publications collectively contribute to scientific literature through experimental evidence and peer-reviewed communication. Representative research articles include publications with Digital Object Identifiers (DOIs), enabling persistent scholarly access.[2]

Research Impact

Citation-based indicators provide evidence that the published research has received attention from the broader scientific community. The available Scopus metrics indicate 116 citations across five indexed documents with an h-index of 3, reflecting measurable academic influence and continued relevance within drug development research.[1]

Award Suitability

Based on the available scholarly indicators, Sallysamir Zahran demonstrates characteristics commonly associated with academic recognition, including peer-reviewed publications, international indexing, measurable citation performance, and contributions to drug development research. The research portfolio aligns with the objectives of the Global Scientist Day Awards, which recognize scientific excellence, innovation, and continued advancement of research across diverse disciplines.[3]

Conclusion

Sallysamir Zahran has established a recognized research profile within the field of drug development through scholarly publications, citation impact, and international indexing. The documented research activities contribute to scientific knowledge while supporting continued innovation in pharmaceutical and biomedical sciences. The available academic record reflects meaningful participation in global research and represents a profile suitable for consideration within international scientific recognition programs.[1]

References

  1. Elsevier. (2026). Scopus Author Details: Sallysamir Zahran, Author ID 56490517500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56490517500
  2. Novel pyrrole-sulfonamide derivatives as EGFR inhibitors and radiosensitizers in lung cancer.
    http://10.1016/j.bioorg.2025.109173
  3. Global Scientist Day Awards. (2026). Official Award Website.
    https://scientistday.org/

Marko Radulovic | Precision Medicine | Research Excellence Award

Published on by Scientist Day

Research Excellence Award – Marko Radulovic

Marko Radulovic

Institute for Oncology and Radiology, Serbia

Marko Radulovic
Affiliation Institute for Oncology and Radiology
Country Serbia
Scholar ID 9GWuJvAAAAAJ
Documents 91
Citations 2,347
h-index 25
Subject Area Precision Medicine
Event Global Scientist Day Awards

Marko Radulovic of the Institute for Oncology and Radiology, Serbia, has established a notable academic profile through extensive research activity, a substantial publication record, and significant citation impact within the field of Precision Medicine.[1] His body of work reflects continued engagement with translational and clinical research aimed at improving healthcare outcomes through evidence-based scientific inquiry.[2]

Abstract

This article presents an academic recognition profile of Marko Radulovic in consideration for the Research Excellence Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and disciplinary engagement in Precision Medicine. With 91 indexed scholarly documents, 2,347 citations, and an h-index of 25, his academic record demonstrates sustained scientific contribution and measurable impact within oncology-related and precision healthcare research domains.[1]

Keywords

Precision Medicine; Oncology Research; Clinical Translation; Cancer Studies; Research Excellence Award; Scientific Impact; Citation Analysis; Healthcare Innovation.

Introduction

Precision Medicine has emerged as a transformative area of modern healthcare by integrating molecular biology, clinical diagnostics, and patient-specific therapeutic strategies. Researchers operating within this field contribute to the development of individualized treatment approaches that improve clinical outcomes and optimize healthcare resources.[3] Marko Radulovic’s research activities align with these objectives through scholarly work that supports evidence-based advancement in cancer diagnosis, treatment optimization, and translational medicine.[2]

Research Profile

Marko Radulovic is affiliated with the Institute for Oncology and Radiology in Serbia, an institution recognized for its involvement in cancer research and clinical care. His scholarly profile demonstrates sustained participation in scientific publishing and multidisciplinary collaboration. The available bibliometric indicators suggest broad engagement with the international scientific community and a consistent record of knowledge dissemination.[1]

  • Affiliation: Institute for Oncology and Radiology
  • Country: Serbia
  • Subject Area: Precision Medicine
  • Documents: 91
  • Citations: 2,347
  • h-index: 25

Research Contributions

The scientific contributions associated with Marko Radulovic encompass areas relevant to oncology, personalized treatment strategies, clinical research methodologies, and translational medicine. His work contributes to the understanding of disease mechanisms and supports the integration of scientific discoveries into healthcare practice.[2]

  • Advancement of precision-based clinical approaches.
  • Contribution to oncology-related scientific literature.
  • Support for evidence-driven patient management strategies.
  • Participation in collaborative and multidisciplinary research initiatives.
  • Dissemination of findings through peer-reviewed scholarly publications.

Publications

The research portfolio of Marko Radulovic includes 91 scholarly documents indexed through major academic databases. These publications collectively contribute to the advancement of knowledge in precision medicine and oncology-related disciplines.[1]

  1. Peer-reviewed research articles.
  2. Clinical and translational research studies.
  3. Collaborative multidisciplinary publications.
  4. Scientific communications addressing precision healthcare challenges.

Research Impact

Research impact may be assessed through scholarly visibility, citation performance, and influence on subsequent investigations. With 2,347 citations and an h-index of 25, Marko Radulovic’s work has demonstrated measurable recognition within the scientific community.[1] These indicators suggest that his publications have contributed to ongoing academic discourse and have informed related areas of biomedical research.[2]

Award Suitability

Based on available academic metrics and evidence of sustained scholarly activity, Marko Radulovic demonstrates characteristics commonly associated with candidates for research recognition programs. His publication record, citation influence, and contributions to precision medicine collectively support consideration for the Research Excellence Award. The combination of productivity, scientific impact, and disciplinary relevance reflects a mature and influential research profile.[1]

Conclusion

Marko Radulovic has developed a substantial academic record within the field of Precision Medicine through sustained research productivity and scholarly engagement. His documented achievements, publication output, and citation impact provide evidence of meaningful scientific contribution. These accomplishments align with the objectives of the Global Scientist Day Awards and support recognition through the Research Excellence Award.[1]

References

  1. Google Scholar. (n.d.). Marko Radulovic Citation Profile and Scholarly Metrics. Google Scholar. https://scholar.google.com/citations?user=9GWuJvAAAAAJ&hl=en&oi=ao
  2. Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder.
    https://ieeexplore.ieee.org/abstract/document/8664469
  3. Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors.
    https://www.tandfonline.com/doi/abs/10.3109/10606820213678
  4. Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. https://academic.oup.com/jimmunol/article-abstract/162/5/3013/8041238

Simon Podnar | Medical Discoveries | Research Excellence Award

Published on by Scientist Day

Prof. Simon Podnar | Medical Discoveries | Research Excellence Award

University Medical Centre Ljubljana | Slovenia

Prof. Simon Podnar, MD, DSc, is a distinguished neurologist and clinical neurophysiologist at the University of Ljubljana and the University Medical Center Ljubljana. He specializes in electromyography, neuromuscular imaging, and advanced neurophysiological diagnostics, with international training across Europe and the United States. He introduced neuromuscular ultrasonography to Slovenia and has held major leadership roles in national and international neurological societies. He leads Slovenia’s only state-funded clinical neurological research program, serves on leading journal editorial boards, and has authored over 400 scientific works, including influential discoveries in neuromuscular and peripheral nerve disorders.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

Citations
2,724

Documents
132

h-index
30

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

Ahmed Hamdan | Pharmaceutical and Clinical Sciences | Research Excellence Award

Published on by Scientist Day

Dr. Ahmed Hamdan | Pharmaceutical and Clinical Sciences | Research Excellence Award

University of Tabuk | Saudi Arabia

Dr. Ahmed Mohsen Elsaid Hamdan is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Tabuk, with more than 14 years of academic and research experience in pharmaceutical sciences. His research is centered on chronopharmacology, chronotherapeutics, and smart drug delivery systems, with a strong translational focus on neurological and neurodevelopmental disorders. His work aims to elucidate how biological rhythms and circadian regulation influence drug efficacy, toxicity, and disease progression. A major theme of Dr. Hamdan’s research is the development of evidence-based non-pharmacological and nutritional therapeutic strategies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases, as well as neurodevelopmental disorders including autism spectrum disorder and ADHD. He extensively investigates phytochemicals, probiotics (particularly Lactobacillus species), and nutraceuticals, emphasizing the gut–microbiome–brain axis as a key mechanistic pathway. His studies integrate pharmacological, behavioral, biochemical, and molecular approaches to identify novel therapeutic targets and mechanisms. In parallel, Dr. Hamdan has contributed significantly to advanced nano- and smart drug delivery systems for cancer therapy, dermatological disorders, infectious diseases, and chronic inflammatory conditions, enhancing drug bioavailability and therapeutic outcomes. His research portfolio also includes hepatoprotective and cardioprotective strategies and chronopharmacological exploration of natural products. Dr. Hamdan has published 105 peer-reviewed articles, with the majority appearing in high-impact Q1–Q2 journals, and holds an h-index of 26. He has secured 13 competitive research grants, is involved in an ongoing patent, and maintains active collaborations with national and international institutions, reflecting his strong commitment to innovative and multidisciplinary biomedical research.

Citation Metrics (Scopus)

1300
900
500
100
    0

Citations
1,047

Documents
69

h-index
19

Citations

Documents

h-index


View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications

Rolf Teschke | Precision Medicine | Best Academic Researcher Award

Published on by Scientist Day

Prof. Rolf Teschke | Precision Medicine | Best Academic Researcher Award

Prof. Rolf Teschke | Klinikum Hanau | Germany

Rolf Teschke, M.D., Professor of Medicine, is a distinguished German physician and internationally recognized expert in gastroenterology, hepatology, and the complex mechanisms of hepatotoxicity. Born in Gera, he pursued medical studies at the universities of Munich and Marburg, earning his medical degree and completing his inaugural thesis. His early scientific foundation was shaped in pathology, where his interest in liver injury and toxic mechanisms first took root. A pivotal stage of his career unfolded in New York, where he worked under the mentorship of renowned liver specialist Charles S. Lieber. During this period, he conducted influential biochemical research on alcohol-related liver injury, including solubilizing and isolating the microsomal ethanol-oxidizing system and exploring cytochrome P450–related pathways. This work strengthened his commitment to uncovering the biological foundations of hepatotoxicity and decisively shaped his future research direction. Returning to Germany, Professor Teschke continued to advance academically in gastroenterology, hepatology, and infectious diseases at the Heinrich Heine University of Düsseldorf. He completed his habilitation, received a prestigious university research award, and expanded his clinical and experimental work on alcohol-induced liver damage, hydrocarbon toxicity, and the growing challenge of drug-induced liver injury. As a department director at a major teaching hospital, he further deepened his focus on drug-induced liver injury, contributing significantly to the development and refinement of the RUCAM causality assessment method in collaboration with international experts. His scholarly output is substantial, consisting of more than 250 English-language publications, including books and book chapters. His work has earned 6,890 citations across 4,042 documents, with an h-index of 48, reflecting his strong influence in the global hepatology community. He has served as associate editor of Annals of Hepatology and held editorial roles across numerous leading medical and scientific journals.

Profile; Scopus | Orcid | Research Gate

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Ahsan Khan | Biomedical Engineering | Research Excellence Award

Published on by Scientist Day

Dr. Ahsan Khan | Biomedical Engineering | Research Excellence Award

Dr. Ahsan Khan | Tongji University | China

Dr. Ahsan Riaz Khan is an accomplished researcher specializing in chemical engineering, environmental sciences, corrosion science, surface engineering, and biomaterials. He holds advanced academic qualifications in Chemical Engineering and Environmental Sciences, complemented by strong interdisciplinary training across materials development, environmental health, and biomedical applications. He is currently serving as a Postdoctoral Researcher at the School of Medicine, Tongji University, Shanghai, where he contributes to cutting-edge research on biomaterials, corrosion-resistant surfaces, biocompatibility, drug-release systems, and in-vivo/in-vitro implant evaluations. Dr. Khan’s research expertise spans the development of novel, sustainable, and cost-effective coating materials; surface modification of metals and alloys; tribology; anticorrosion technology; adhesion engineering; electrochemical methods; and advanced techniques in cell culture, toxicity analysis, and immunohistochemistry. His interdisciplinary background enables him to work at the intersection of engineering, materials science, medicine, and environmental sustainability. He has published 28 peer-reviewed research papers, contributing significantly to high-impact journals in materials science, corrosion protection, biomaterials, environmental pollution, electrochemistry, and regenerative medicine. His publications have received over 330 citations with an H-index above 10, reflecting strong academic influence and global research engagement. His work includes notable contributions to magnesium alloys, smart scaffolds, hybrid biomaterials, environmental risk assessments, supercapacitive materials, and psychological health investigations. Dr. Khan has earned multiple academic honors, including innovation awards, competitive scholarships, excellence certificates, and internship recognitions. He has participated in a wide range of international conferences, workshops, and training programs in environmental management, materials engineering, GIS, chemical engineering, and waste management. Skilled in a broad array of analytical and characterization techniques—such as SEM, TEM, XPS, XRD, TGA, ICP-OES, GC-MS, Raman spectroscopy, and electrochemical workstations—Dr. Khan combines technical depth with strong research leadership. Fluent in English, Urdu, and conversational Chinese (HSK-3), he remains committed to advancing global research in materials innovation, corrosion engineering, environmental sustainability, and biomedical technology.

Profile: Google Scholar

Featured Publications

Khan, A. R., Grewal, N. S., Zhou, C., Yuan, K., Zhang, H. J., & Jun, Z. Recent advances in biodegradable metals for implant applications: Exploring in vivo and in vitro responses. Results in Engineering, 20, 101526.

Zafar, Z., Mehmood, M. S., Ahamad, M. I., Chudhary, A., Abbas, N., Khan, A. R., … Trend analysis of the decadal variations of water bodies and land use/land cover through MODIS imagery: An in-depth study from Gilgit-Baltistan, Pakistan. Water Supply, 21(2), 927–940.

Rehman, A. U., Shah, M. Z., Ali, A., Zhao, T., Shah, R., Ullah, I., Bilal, H., Khan, A. R., … Thermochemical heat storage ability of ZnSO₄·7H₂O as potential long-term heat storage material. International Journal of Energy Research, 45(3), 4746–4754.

Khan, M., Tiehu, L., Hussain, A., Raza, A., Zada, A., Alei, D., Khan, A. R., Ali, R., … Physiochemical evaluations, mechanical attenuations and thermal stability of graphene nanosheets and functionalized nanodiamonds loaded pitch-derived carbon foam composites. Diamond and Related Materials, 126, 109077.

Khan, Z. U., Razzaq, A., Khan, A., Rehman, N. U., Khan, H., Khan, T., Khan, A. U., … Physicochemical characterizations and pharmacokinetic evaluation of pentazocine solid lipid nanoparticles against inflammatory pain model. Pharmaceutics, 14(2), 409.

Sylvia Mangani | Medical Discoveries | Best Researcher Award

Published on by Scientist Day

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161

Diane Harper | Precision Medicine | Distinguished Scientist Award

Published on by Scientist Day

Prof. Dr Diane Harper | Precision Medicine | Distinguished Scientist Award

Prof. Dr Diane Harper | University of MIchigan | United States

Prof. Dr. Diane M. Harper is a globally recognized physician-scientist, educator, and leader in women’s health, family medicine, and preventive oncology. She earned her SB and SM degrees in Chemical Engineering and Polymerics from the Massachusetts Institute of Technology (MIT), followed by her MD and MPH in Biostatistics/Epidemiology from the University of Kansas Medical School. Complementing her medical and public health expertise, she completed numerous prestigious postgraduate fellowships and executive leadership programs, including the Executive Leadership in Academic Medicine (ELAM) Program, University of Michigan Ross School of Business Leadership Development, and US PHS Primary Care Fellowship in Washington, D.C. Over her distinguished career, Dr. Harper has held senior academic and administrative appointments at leading institutions including Dartmouth College, University of Missouri–Kansas City, University of Louisville, and currently the University of Michigan, where she serves as a Professor of Family Medicine, Obstetrics and Gynecology, and Women’s and Gender Studies, and Affiliate Faculty in Biomedical Engineering. Her interdisciplinary expertise bridges medicine, engineering, and public health to improve women’s health outcomes worldwide. Internationally acclaimed for her pioneering work on Human Papillomavirus (HPV) and cervical cancer prevention, Dr. Harper has been instrumental in the development and clinical validation of HPV vaccines, advancing screening technologies, and establishing evidence-based guidelines for HPV-associated disease management. Her research spans clinical trials, shared decision-making, health equity, and policy reform, emphasizing underserved and physically disabled populations.

Profiles: Google Scholar

Featured Publications

Quinn, J. A., Munoz, F. M., Gonik, B., Frau, L., Cutland, C., Mallett-Moore, T., … & Harper, D. M. (2016). Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine, 34(49), 6047–6056.

Harper, D. M., DeMars, L. R. (2017). HPV vaccines – A review of the first decade. Gynecologic Oncology, 146(1), 196–204.

Tota, J. E., Struyf, F., Merikukka, M., Gonzalez, P., Kreimer, A. R., Bi, D., … & Harper, D. M. (2017). Evaluation of type replacement following HPV16/18 vaccination: pooled analysis of two randomized trials. Journal of the National Cancer Institute, 109(7), djw300.

Gorin, S. S., Jimbo, M., Heizelman, R., Harmes, K. M., & Harper, D. M. (2021). The future of cancer screening after COVID‐19 may be at home. Wiley Periodicals, Inc.

Dykens, J. A., Peterson, C. E., Holt, H. K., & Harper, D. M. (2023). Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally. Frontiers in Public Health, 11, 1067299.

Amit Gupta | Drug Development | Best Faculty Award

Published on by Scientist Day

Dr. Amit Gupta | Drug Development | Best Faculty Award

Dr. Amit Gupta | Chemistry Department Institute of Basic Sciences Dr. B R Ambedkar University Agra | India

Dr. Amit Gupta is a distinguished chemist with an extensive academic background in organic and inorganic chemistry, complemented by a doctoral degree in the study of mercury peroxychromate complexes. With a long teaching career spanning undergraduate to doctoral levels, he has significantly contributed to shaping future researchers and advancing chemical education. His research interests cover coordination chemistry, phytochemistry, and trace metal analysis, with numerous publications and books to his credit. Recognized through awards and active participation in national and international conferences, he continues to make impactful contributions to the fields of chemistry and pharmaceutical sciences.

Academic Profile 

Scopus | Orcid | Google Scholar

Education

Dr. Amit Gupta holds dual Master’s degrees in Organic and Inorganic Chemistry, followed by a Ph.D. in Chemistry from Dr. B. R. Ambedkar University, Agra. His doctoral research focused on the study of mercury peroxychromate and its complexes with nitrogen bases, which provided him with a strong foundation in coordination chemistry and analytical techniques. He has also earned the distinction of being a Fellow of the Indian Council of Chemists (FICC) and has pursued specialized certification in data analysis for life sciences. His academic journey reflects both breadth and depth in chemical sciences, establishing a solid base for his teaching and research career.

Experience

Dr. Gupta has more than two decades of rich teaching experience across undergraduate, postgraduate, and doctoral levels. He has taught B.Sc., M.Sc., M.Phil., and Ph.D. coursework in chemistry and has guided students with academic rigor and research orientation. He has contributed to the academic growth of institutions by teaching core subjects and mentoring research scholars. His long-standing association with the Department of Chemistry at the Institute of Basic Science, Dr. B. R. Ambedkar University, has enabled him to play a pivotal role in shaping future scientists. Alongside teaching, he has authored textbooks in inorganic, organic, and physical chemistry, further extending his impact on the academic community.

Research Interests

Dr. Gupta’s research interests lie in inorganic and coordination chemistry, phytochemistry, and trace metal analysis. He has extensively studied peroxychromates and their complexes, exploring their oxidative behavior and decomposition pathways. His later research expanded into phytochemical screening and the isolation of bioactive compounds from medicinal plants, including studies on flavonoids and antioxidants. He has also investigated trace and heavy metal accumulation in plant systems using modern analytical methods, linking his work to environmental chemistry and human health. His publications reflect a blend of fundamental chemical studies and applied research with multidisciplinary relevance.

Awards and Recognition

Dr. Gupta has been recognized for his academic and research contributions through awards and honors at inter-collegiate and professional platforms. His first-prize achievement in an e-poster competition on nanomaterials and quantum dots highlights his ability to connect advanced concepts in chemistry with innovative presentation. He has actively participated in numerous national and international conferences, workshops, and seminars, showcasing his research and engaging in scholarly exchange. His membership as FICC further underscores his standing in the professional chemistry community, marking him as a respected educator, researcher, and contributor to the advancement of chemical sciences.

Publications

Isolation and characterization of flavonoid glycoside from leaves of Abrus precatorius

Authors: J. Gupta, G. Amit
Journal: International Journal of Chemical Studies
Year: 2014

Determination of trace metals in the leaves of Rauwolfia serpentina by using atomic absorption spectroscopy

Authors: J. Gupta, A. Gupta
Journal: International Journal of Chemical Studies
Year: 2016

Isolation and identification of flavonoid rutin from Rauwolfia serpentina

Authors: J. Gupta, A. Gupta
Journal: International Journal of Chemical Studies
Year: 2015

 Preliminary phytochemical screening of leaves of Moringa oleifera Lam

Authors: J. Gupta, A. Gupta, K. Gupta
Journal: Journal Chemtracks
Year: 2014

Isolation and characterization of flavonoid from leaves of Abrus precatorius

Authors: J. Gupta, A. Gupta
Journal: International Journal of Current Research in Chemistry and Pharmaceutical Sciences
Year: 2016

Studies on the chemical constituents of leaves of Phyllanthus emblica (L.)

Authors: J. Gupta, A. Gupta, A.K. Gupta
Journal: Oriental Journal of Chemistry
Year: 2014

Extraction and identification of flavonoid natural antioxidant in the leaves of Rauwolfia serpentina

Authors: J. Gupta, A. Gupta, A.K. Gupta
Journal: International Journal of Chemical Studies
Year: 2016

Conclusion

Dr. Amit Gupta’s outstanding academic journey, extensive teaching experience, and impactful research contributions make him a distinguished scholar in the field of chemistry. His dedication to advancing scientific knowledge, mentoring future researchers, and publishing widely demonstrates both depth and breadth of expertise. With a proven record of innovation and commitment to excellence, he is a highly deserving candidate for the Best Faculty Award.